eF-site ID 5lvp-ABCDEFGH
PDB Code 5lvp
Chain A, B, C, D, E, F, G, H

click to enlarge
Title Human PDK1 Kinase Domain in Complex with an HM-Peptide Bound to the PIF-Pocket
Classification TRANSFERASE
Compound 3-phosphoinositide-dependent protein kinase 1
Source (5LVP)
Sequence A:  RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILE
KRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK
LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE
YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLNXFV
GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR
AGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLDATK
RLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT
B:  PRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKIL
EKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE
KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL
EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSXF
VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF
RAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLDAT
KRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT
C:  RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILE
KRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK
LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE
YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLNXFV
GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR
AGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLDATK
RLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT
D:  PRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKIL
EKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE
KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL
EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLNXF
VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF
RAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLDAT
KRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT
E:  FPQFXYS
F:  FPQFXYSA
G:  FPQFXYSA
H:  FPQFXYS
Description (1)  3-phosphoinositide-dependent protein kinase 1 (E.C.2.7.11.1), hydrophobic-motif peptide of PKB/Akt


Functional site

1) chain A
residue 89
type
sequence G
description binding site for residue ATP A 500
source : AC1

2) chain A
residue 91
type
sequence G
description binding site for residue ATP A 500
source : AC1

3) chain A
residue 92
type
sequence S
description binding site for residue ATP A 500
source : AC1

4) chain A
residue 94
type
sequence S
description binding site for residue ATP A 500
source : AC1

5) chain A
residue 96
type
sequence V
description binding site for residue ATP A 500
source : AC1

6) chain A
residue 109
type
sequence A
description binding site for residue ATP A 500
source : AC1

7) chain A
residue 111
type
sequence K
description binding site for residue ATP A 500
source : AC1

8) chain A
residue 160
type
sequence S
description binding site for residue ATP A 500
source : AC1

9) chain A
residue 162
type
sequence A
description binding site for residue ATP A 500
source : AC1

10) chain A
residue 166
type
sequence E
description binding site for residue ATP A 500
source : AC1

11) chain A
residue 212
type
sequence L
description binding site for residue ATP A 500
source : AC1

12) chain B
residue 89
type
sequence G
description binding site for residue ATP B 401
source : AC2

13) chain B
residue 91
type
sequence G
description binding site for residue ATP B 401
source : AC2

14) chain B
residue 92
type
sequence S
description binding site for residue ATP B 401
source : AC2

15) chain B
residue 94
type
sequence S
description binding site for residue ATP B 401
source : AC2

16) chain B
residue 96
type
sequence V
description binding site for residue ATP B 401
source : AC2

17) chain B
residue 109
type
sequence A
description binding site for residue ATP B 401
source : AC2

18) chain B
residue 111
type
sequence K
description binding site for residue ATP B 401
source : AC2

19) chain B
residue 160
type
sequence S
description binding site for residue ATP B 401
source : AC2

20) chain B
residue 162
type
sequence A
description binding site for residue ATP B 401
source : AC2

21) chain B
residue 166
type
sequence E
description binding site for residue ATP B 401
source : AC2

22) chain B
residue 212
type
sequence L
description binding site for residue ATP B 401
source : AC2

23) chain C
residue 89
type
sequence G
description binding site for residue ATP C 401
source : AC3

24) chain C
residue 91
type
sequence G
description binding site for residue ATP C 401
source : AC3

25) chain C
residue 92
type
sequence S
description binding site for residue ATP C 401
source : AC3

26) chain C
residue 94
type
sequence S
description binding site for residue ATP C 401
source : AC3

27) chain C
residue 96
type
sequence V
description binding site for residue ATP C 401
source : AC3

28) chain C
residue 109
type
sequence A
description binding site for residue ATP C 401
source : AC3

29) chain C
residue 111
type
sequence K
description binding site for residue ATP C 401
source : AC3

30) chain C
residue 160
type
sequence S
description binding site for residue ATP C 401
source : AC3

31) chain C
residue 162
type
sequence A
description binding site for residue ATP C 401
source : AC3

32) chain C
residue 166
type
sequence E
description binding site for residue ATP C 401
source : AC3

33) chain C
residue 209
type
sequence E
description binding site for residue ATP C 401
source : AC3

34) chain C
residue 212
type
sequence L
description binding site for residue ATP C 401
source : AC3

35) chain C
residue 144
type
sequence K
description binding site for residue CL C 402
source : AC4

36) chain D
residue 89
type
sequence G
description binding site for residue ATP D 500
source : AC5

37) chain D
residue 90
type
sequence E
description binding site for residue ATP D 500
source : AC5

38) chain D
residue 91
type
sequence G
description binding site for residue ATP D 500
source : AC5

39) chain D
residue 92
type
sequence S
description binding site for residue ATP D 500
source : AC5

40) chain D
residue 94
type
sequence S
description binding site for residue ATP D 500
source : AC5

41) chain D
residue 96
type
sequence V
description binding site for residue ATP D 500
source : AC5

42) chain D
residue 109
type
sequence A
description binding site for residue ATP D 500
source : AC5

43) chain D
residue 111
type
sequence K
description binding site for residue ATP D 500
source : AC5

44) chain D
residue 160
type
sequence S
description binding site for residue ATP D 500
source : AC5

45) chain D
residue 162
type
sequence A
description binding site for residue ATP D 500
source : AC5

46) chain D
residue 166
type
sequence E
description binding site for residue ATP D 500
source : AC5

47) chain D
residue 212
type
sequence L
description binding site for residue ATP D 500
source : AC5

48) chain C
residue 131
type
sequence R
description binding site for Di-peptide PHE E 11 and SEP E 12
source : AC6

49) chain C
residue 148
type
sequence T
description binding site for Di-peptide PHE E 11 and SEP E 12
source : AC6

50) chain C
residue 149
type
sequence F
description binding site for Di-peptide PHE E 11 and SEP E 12
source : AC6

51) chain C
residue 150
type
sequence Q
description binding site for Di-peptide PHE E 11 and SEP E 12
source : AC6

52) chain E
residue 8
type
sequence F
description binding site for Di-peptide PHE E 11 and SEP E 12
source : AC6

53) chain E
residue 9
type
sequence P
description binding site for Di-peptide PHE E 11 and SEP E 12
source : AC6

54) chain E
residue 10
type
sequence Q
description binding site for Di-peptide PHE E 11 and SEP E 12
source : AC6

55) chain E
residue 13
type
sequence Y
description binding site for Di-peptide PHE E 11 and SEP E 12
source : AC6

56) chain C
residue 145
type
sequence L
description binding site for Di-peptide SEP E 12 and TYR E 13
source : AC7

57) chain C
residue 147
type
sequence F
description binding site for Di-peptide SEP E 12 and TYR E 13
source : AC7

58) chain C
residue 148
type
sequence T
description binding site for Di-peptide SEP E 12 and TYR E 13
source : AC7

59) chain C
residue 150
type
sequence Q
description binding site for Di-peptide SEP E 12 and TYR E 13
source : AC7

60) chain E
residue 8
type
sequence F
description binding site for Di-peptide SEP E 12 and TYR E 13
source : AC7

61) chain E
residue 10
type
sequence Q
description binding site for Di-peptide SEP E 12 and TYR E 13
source : AC7

62) chain E
residue 11
type
sequence F
description binding site for Di-peptide SEP E 12 and TYR E 13
source : AC7

63) chain E
residue 14
type
sequence S
description binding site for Di-peptide SEP E 12 and TYR E 13
source : AC7

64) chain A
residue 131
type
sequence R
description binding site for Di-peptide PHE F 11 and SEP F 12
source : AC8

65) chain A
residue 148
type
sequence T
description binding site for Di-peptide PHE F 11 and SEP F 12
source : AC8

66) chain A
residue 149
type
sequence F
description binding site for Di-peptide PHE F 11 and SEP F 12
source : AC8

67) chain A
residue 150
type
sequence Q
description binding site for Di-peptide PHE F 11 and SEP F 12
source : AC8

68) chain A
residue 157
type
sequence F
description binding site for Di-peptide PHE F 11 and SEP F 12
source : AC8

69) chain F
residue 8
type
sequence F
description binding site for Di-peptide PHE F 11 and SEP F 12
source : AC8

70) chain F
residue 9
type
sequence P
description binding site for Di-peptide PHE F 11 and SEP F 12
source : AC8

71) chain F
residue 10
type
sequence Q
description binding site for Di-peptide PHE F 11 and SEP F 12
source : AC8

72) chain F
residue 13
type
sequence Y
description binding site for Di-peptide PHE F 11 and SEP F 12
source : AC8

73) chain A
residue 135
type
sequence S
description binding site for Di-peptide SEP F 12 and TYR F 13
source : AC9

74) chain A
residue 147
type
sequence F
description binding site for Di-peptide SEP F 12 and TYR F 13
source : AC9

75) chain A
residue 148
type
sequence T
description binding site for Di-peptide SEP F 12 and TYR F 13
source : AC9

76) chain A
residue 150
type
sequence Q
description binding site for Di-peptide SEP F 12 and TYR F 13
source : AC9

77) chain F
residue 9
type
sequence P
description binding site for Di-peptide SEP F 12 and TYR F 13
source : AC9

78) chain F
residue 10
type
sequence Q
description binding site for Di-peptide SEP F 12 and TYR F 13
source : AC9

79) chain F
residue 11
type
sequence F
description binding site for Di-peptide SEP F 12 and TYR F 13
source : AC9

80) chain F
residue 14
type
sequence S
description binding site for Di-peptide SEP F 12 and TYR F 13
source : AC9

81) chain B
residue 131
type
sequence R
description binding site for Di-peptide PHE G 11 and SEP G 12
source : AD1

82) chain B
residue 148
type
sequence T
description binding site for Di-peptide PHE G 11 and SEP G 12
source : AD1

83) chain B
residue 150
type
sequence Q
description binding site for Di-peptide PHE G 11 and SEP G 12
source : AD1

84) chain B
residue 157
type
sequence F
description binding site for Di-peptide PHE G 11 and SEP G 12
source : AD1

85) chain G
residue 8
type
sequence F
description binding site for Di-peptide PHE G 11 and SEP G 12
source : AD1

86) chain G
residue 9
type
sequence P
description binding site for Di-peptide PHE G 11 and SEP G 12
source : AD1

87) chain G
residue 10
type
sequence Q
description binding site for Di-peptide PHE G 11 and SEP G 12
source : AD1

88) chain G
residue 13
type
sequence Y
description binding site for Di-peptide PHE G 11 and SEP G 12
source : AD1

89) chain B
residue 147
type
sequence F
description binding site for Di-peptide SEP G 12 and TYR G 13
source : AD2

90) chain B
residue 148
type
sequence T
description binding site for Di-peptide SEP G 12 and TYR G 13
source : AD2

91) chain B
residue 150
type
sequence Q
description binding site for Di-peptide SEP G 12 and TYR G 13
source : AD2

92) chain G
residue 9
type
sequence P
description binding site for Di-peptide SEP G 12 and TYR G 13
source : AD2

93) chain G
residue 10
type
sequence Q
description binding site for Di-peptide SEP G 12 and TYR G 13
source : AD2

94) chain G
residue 11
type
sequence F
description binding site for Di-peptide SEP G 12 and TYR G 13
source : AD2

95) chain G
residue 14
type
sequence S
description binding site for Di-peptide SEP G 12 and TYR G 13
source : AD2

96) chain D
residue 131
type
sequence R
description binding site for Di-peptide PHE H 11 and SEP H 12
source : AD3

97) chain D
residue 148
type
sequence T
description binding site for Di-peptide PHE H 11 and SEP H 12
source : AD3

98) chain D
residue 149
type
sequence F
description binding site for Di-peptide PHE H 11 and SEP H 12
source : AD3

99) chain D
residue 150
type
sequence Q
description binding site for Di-peptide PHE H 11 and SEP H 12
source : AD3

100) chain D
residue 155
type
sequence L
description binding site for Di-peptide PHE H 11 and SEP H 12
source : AD3

101) chain D
residue 157
type
sequence F
description binding site for Di-peptide PHE H 11 and SEP H 12
source : AD3

102) chain H
residue 8
type
sequence F
description binding site for Di-peptide PHE H 11 and SEP H 12
source : AD3

103) chain H
residue 9
type
sequence P
description binding site for Di-peptide PHE H 11 and SEP H 12
source : AD3

104) chain H
residue 10
type
sequence Q
description binding site for Di-peptide PHE H 11 and SEP H 12
source : AD3

105) chain H
residue 13
type
sequence Y
description binding site for Di-peptide PHE H 11 and SEP H 12
source : AD3

106) chain D
residue 135
type
sequence S
description binding site for Di-peptide SEP H 12 and TYR H 13
source : AD4

107) chain D
residue 145
type
sequence L
description binding site for Di-peptide SEP H 12 and TYR H 13
source : AD4

108) chain D
residue 148
type
sequence T
description binding site for Di-peptide SEP H 12 and TYR H 13
source : AD4

109) chain D
residue 150
type
sequence Q
description binding site for Di-peptide SEP H 12 and TYR H 13
source : AD4

110) chain H
residue 10
type
sequence Q
description binding site for Di-peptide SEP H 12 and TYR H 13
source : AD4

111) chain H
residue 11
type
sequence F
description binding site for Di-peptide SEP H 12 and TYR H 13
source : AD4

112) chain H
residue 14
type
sequence S
description binding site for Di-peptide SEP H 12 and TYR H 13
source : AD4

113) chain A
residue 205
type ACT_SITE
sequence D
description Proton acceptor => ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027
source Swiss-Prot : SWS_FT_FI1

114) chain B
residue 205
type ACT_SITE
sequence D
description Proton acceptor => ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027
source Swiss-Prot : SWS_FT_FI1

115) chain C
residue 205
type ACT_SITE
sequence D
description Proton acceptor => ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027
source Swiss-Prot : SWS_FT_FI1

116) chain D
residue 205
type ACT_SITE
sequence D
description Proton acceptor => ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027
source Swiss-Prot : SWS_FT_FI1

117) chain A
residue 92
type BINDING
sequence S
description BINDING => ECO:0000269|PubMed:12169624, ECO:0000269|PubMed:15741170, ECO:0000269|PubMed:22999883
source Swiss-Prot : SWS_FT_FI2

118) chain B
residue 223
type BINDING
sequence D
description BINDING => ECO:0000269|PubMed:12169624, ECO:0000269|PubMed:15741170, ECO:0000269|PubMed:22999883
source Swiss-Prot : SWS_FT_FI2

119) chain C
residue 92
type BINDING
sequence S
description BINDING => ECO:0000269|PubMed:12169624, ECO:0000269|PubMed:15741170, ECO:0000269|PubMed:22999883
source Swiss-Prot : SWS_FT_FI2

120) chain C
residue 111
type BINDING
sequence K
description BINDING => ECO:0000269|PubMed:12169624, ECO:0000269|PubMed:15741170, ECO:0000269|PubMed:22999883
source Swiss-Prot : SWS_FT_FI2

121) chain C
residue 160
type BINDING
sequence S
description BINDING => ECO:0000269|PubMed:12169624, ECO:0000269|PubMed:15741170, ECO:0000269|PubMed:22999883
source Swiss-Prot : SWS_FT_FI2

122) chain C
residue 166
type BINDING
sequence E
description BINDING => ECO:0000269|PubMed:12169624, ECO:0000269|PubMed:15741170, ECO:0000269|PubMed:22999883
source Swiss-Prot : SWS_FT_FI2

123) chain C
residue 223
type BINDING
sequence D
description BINDING => ECO:0000269|PubMed:12169624, ECO:0000269|PubMed:15741170, ECO:0000269|PubMed:22999883
source Swiss-Prot : SWS_FT_FI2

124) chain D
residue 92
type BINDING
sequence S
description BINDING => ECO:0000269|PubMed:12169624, ECO:0000269|PubMed:15741170, ECO:0000269|PubMed:22999883
source Swiss-Prot : SWS_FT_FI2

125) chain D
residue 111
type BINDING
sequence K
description BINDING => ECO:0000269|PubMed:12169624, ECO:0000269|PubMed:15741170, ECO:0000269|PubMed:22999883
source Swiss-Prot : SWS_FT_FI2

126) chain D
residue 160
type BINDING
sequence S
description BINDING => ECO:0000269|PubMed:12169624, ECO:0000269|PubMed:15741170, ECO:0000269|PubMed:22999883
source Swiss-Prot : SWS_FT_FI2

127) chain D
residue 166
type BINDING
sequence E
description BINDING => ECO:0000269|PubMed:12169624, ECO:0000269|PubMed:15741170, ECO:0000269|PubMed:22999883
source Swiss-Prot : SWS_FT_FI2

128) chain A
residue 111
type BINDING
sequence K
description BINDING => ECO:0000269|PubMed:12169624, ECO:0000269|PubMed:15741170, ECO:0000269|PubMed:22999883
source Swiss-Prot : SWS_FT_FI2

129) chain D
residue 223
type BINDING
sequence D
description BINDING => ECO:0000269|PubMed:12169624, ECO:0000269|PubMed:15741170, ECO:0000269|PubMed:22999883
source Swiss-Prot : SWS_FT_FI2

130) chain A
residue 160
type BINDING
sequence S
description BINDING => ECO:0000269|PubMed:12169624, ECO:0000269|PubMed:15741170, ECO:0000269|PubMed:22999883
source Swiss-Prot : SWS_FT_FI2

131) chain A
residue 166
type BINDING
sequence E
description BINDING => ECO:0000269|PubMed:12169624, ECO:0000269|PubMed:15741170, ECO:0000269|PubMed:22999883
source Swiss-Prot : SWS_FT_FI2

132) chain A
residue 223
type BINDING
sequence D
description BINDING => ECO:0000269|PubMed:12169624, ECO:0000269|PubMed:15741170, ECO:0000269|PubMed:22999883
source Swiss-Prot : SWS_FT_FI2

133) chain B
residue 92
type BINDING
sequence S
description BINDING => ECO:0000269|PubMed:12169624, ECO:0000269|PubMed:15741170, ECO:0000269|PubMed:22999883
source Swiss-Prot : SWS_FT_FI2

134) chain B
residue 111
type BINDING
sequence K
description BINDING => ECO:0000269|PubMed:12169624, ECO:0000269|PubMed:15741170, ECO:0000269|PubMed:22999883
source Swiss-Prot : SWS_FT_FI2

135) chain B
residue 160
type BINDING
sequence S
description BINDING => ECO:0000269|PubMed:12169624, ECO:0000269|PubMed:15741170, ECO:0000269|PubMed:22999883
source Swiss-Prot : SWS_FT_FI2

136) chain B
residue 166
type BINDING
sequence E
description BINDING => ECO:0000269|PubMed:12169624, ECO:0000269|PubMed:15741170, ECO:0000269|PubMed:22999883
source Swiss-Prot : SWS_FT_FI2

137) chain A
residue 209
type BINDING
sequence E
description BINDING => ECO:0000269|PubMed:22999883
source Swiss-Prot : SWS_FT_FI3

138) chain B
residue 209
type BINDING
sequence E
description BINDING => ECO:0000269|PubMed:22999883
source Swiss-Prot : SWS_FT_FI3

139) chain C
residue 209
type BINDING
sequence E
description BINDING => ECO:0000269|PubMed:22999883
source Swiss-Prot : SWS_FT_FI3

140) chain D
residue 209
type BINDING
sequence E
description BINDING => ECO:0000269|PubMed:22999883
source Swiss-Prot : SWS_FT_FI3

141) chain A
residue 241
type MOD_RES
sequence X
description Phosphoserine; by autocatalysis => ECO:0000269|PubMed:10455013, ECO:0000269|PubMed:11481331, ECO:0000269|PubMed:15772071, ECO:0000269|PubMed:16780920, ECO:0000269|Ref.8
source Swiss-Prot : SWS_FT_FI4

142) chain B
residue 241
type MOD_RES
sequence X
description Phosphoserine; by autocatalysis => ECO:0000269|PubMed:10455013, ECO:0000269|PubMed:11481331, ECO:0000269|PubMed:15772071, ECO:0000269|PubMed:16780920, ECO:0000269|Ref.8
source Swiss-Prot : SWS_FT_FI4

143) chain C
residue 241
type MOD_RES
sequence X
description Phosphoserine; by autocatalysis => ECO:0000269|PubMed:10455013, ECO:0000269|PubMed:11481331, ECO:0000269|PubMed:15772071, ECO:0000269|PubMed:16780920, ECO:0000269|Ref.8
source Swiss-Prot : SWS_FT_FI4

144) chain D
residue 241
type MOD_RES
sequence X
description Phosphoserine; by autocatalysis => ECO:0000269|PubMed:10455013, ECO:0000269|PubMed:11481331, ECO:0000269|PubMed:15772071, ECO:0000269|PubMed:16780920, ECO:0000269|Ref.8
source Swiss-Prot : SWS_FT_FI4

145) chain A
residue 304
type MOD_RES
sequence K
description N6-acetyllysine => ECO:0000250|UniProtKB:Q9Z2A0
source Swiss-Prot : SWS_FT_FI5

146) chain B
residue 304
type MOD_RES
sequence K
description N6-acetyllysine => ECO:0000250|UniProtKB:Q9Z2A0
source Swiss-Prot : SWS_FT_FI5

147) chain C
residue 304
type MOD_RES
sequence K
description N6-acetyllysine => ECO:0000250|UniProtKB:Q9Z2A0
source Swiss-Prot : SWS_FT_FI5

148) chain D
residue 304
type MOD_RES
sequence K
description N6-acetyllysine => ECO:0000250|UniProtKB:Q9Z2A0
source Swiss-Prot : SWS_FT_FI5

149) chain A
residue 354
type MOD_RES
sequence T
description Phosphothreonine; by MELK => ECO:0000269|PubMed:22544756
source Swiss-Prot : SWS_FT_FI6

150) chain B
residue 354
type MOD_RES
sequence T
description Phosphothreonine; by MELK => ECO:0000269|PubMed:22544756
source Swiss-Prot : SWS_FT_FI6

151) chain C
residue 354
type MOD_RES
sequence T
description Phosphothreonine; by MELK => ECO:0000269|PubMed:22544756
source Swiss-Prot : SWS_FT_FI6

152) chain D
residue 354
type MOD_RES
sequence T
description Phosphothreonine; by MELK => ECO:0000269|PubMed:22544756
source Swiss-Prot : SWS_FT_FI6

153) chain A
residue 88-111
type prosite
sequence LGEGSFSTVVLARELATSREYAIK
description PROTEIN_KINASE_ATP Protein kinases ATP-binding region signature. LGEGSFSTVVlArelatsre..........YAIK
source prosite : PS00107

154) chain A
residue 201-213
type prosite
sequence IIHRDLKPENILL
description PROTEIN_KINASE_ST Serine/Threonine protein kinases active-site signature. IiHrDLKpeNILL
source prosite : PS00108


Display surface

Download
Links